Gevokizumab

2 Cited Publications
Kundenbewertung

Based on 2 publication(s) in Google Scholar

Gevokizumab is a potent anti-IL-1β antibody, negatively modulates IL-1β signaling through an allosteric mechanism. Gevokizumab selectively decreases the binding affinity of IL-1β for the IL-1 receptor type I (IL-1RI) signaling receptor instead of IL-1 counter-regulatory decoy receptor (IL-1 receptor type II).

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 98.12%
  • CAS. Nr.: 1129435-60-4
  • Molecular Weight:145.12 kDa
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Gevokizumab

More

Alle Interleukin Related Isoform-spezifische Produkte anzeigen

More
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00